Thorney Technologies Reports October 2026 NTA of 19.3 Cents Per Share, Down from 20.7 Cents

Anjali Anand

12 November 2026 04:51 PM AEDT

Thorney Technologies Reports October 2026 NTA of 19.3 Cents Per Share, Down from 20.7 Cents

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Thorney Technologies (ASX:TEK), an ASX-listed investment company managed by Thorney Investment Group, has disclosed a pre-tax net tangible asset backing per share of 19.3 cents as at 31 October 2026, compared with 20.7 cents recorded at the end of September 2026, according to the company's October 2026 Investment Update and NTA Report.

Key Points

Pre-tax NTA per share was 19.3 cents as at 31 October 2026, down from 20.7 cents at 30 September 2026
TEK's one-month investment portfolio return was -6.76% on a before-tax basis after accrued management fees
Cash held short-term with major banks totalled $6.3 million, with prime broker facilities undrawn
The on-market share buyback purchased 2,145,306 shares during October, with the buyback renewed on 6 November 2026 for a further 12 months
Thorney Investment Group and associates retained a shareholding interest of 33.4%

October 2026 NTA and Portfolio Performance

According to the filing, TEK's pre-tax NTA per share as at 31 October 2026 was 19.3 cents, with the after-tax NTA also recorded at 19.3 cents, as no deferred tax asset was recognised at the reporting date. All figures are stated as unaudited and approximate. The company's investment portfolio returned -6.76% for the one-month period, -26.34% over one year, -4.48% per annum over three years, and -0.73% per annum since inception in January 2017. The filing states that TEK's portfolio was weaker during October with broad declines across the book and few positive performers.

Portfolio Composition and Top Holdings

As at 31 October 2026, TEK's portfolio allocation comprised 53% in listed securities, 38% in unlisted securities, and 9% in cash. The top five listed securities by portfolio weighting were Vitrafy Life Sciences (VFY.ASX) at 4.8%, Mesoblast (MSB.ASX) at 4.1%, Credit Clear (CCR.ASX) at 4.0%, Doctor Care Anywhere (DOC.ASX) at 3.7%, and Imricor Medical Systems (IMR.ASX) at 3.7%. The top unlisted holding was Splitit Payments at 7.2%, followed by Mosh at 5.2%, 360 Capital Fibreconx at 3.0%, Elenium Automation at 2.9%, and WSC Technologies at 2.2%.

Share Buyback Activity and Key Company Data

The filing disclosed that TEK's on-market share buyback was active during October, with 2,145,306 shares purchased over the month. The buyback was subsequently renewed on 6 November 2026 for a further 12 months. As at 31 October 2026, TEK had 350,267,387 shares on issue, a market capitalisation of $32.2 million, and a share price of 9.2 cents. The company is managed by Thorney Investment Group under a management fee of 0.75% half-yearly and a performance fee of 20% of net portfolio increase over the high water mark base half year.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.